Try our Advanced Search for more refined results
Mergers & Acquisitions
-
October 15, 2025
9th Circ. Lets Alaska Flyers Redo Hawaiian Merger Case
The Ninth Circuit found that a lower court was right to toss a case from flyers and travel agents challenging the $1.9 billion merger between Alaska Airlines and Hawaiian Airlines but said they should have been given a chance to revise their allegations.
-
October 15, 2025
Skadden, Kirkland Guiding Lone Star's $3.8B Hillenbrand Buy
Skadden-led Hillenbrand Inc. will be acquired by an affiliate of Kirkland-advised Lone Star Funds in an all-cash transaction with an enterprise value of approximately $3.8 billion, the provider of industrial processing equipment said Wednesday.
-
October 15, 2025
Greenberg Traurig Lands Wilson Sonsini Life Sciences Pro
Greenberg Traurig LLP has added a California partner from Wilson Sonsini Goodrich & Rosati with in-house and government legal experience to enhance its capacity to handle matters for clients in life sciences, artificial intelligence, biotechnology and other industries.
-
October 15, 2025
Alston & Bird-Led TrueCar Goes Private In $227M Deal
Automotive digital marketplace company TrueCar, advised by Alston & Bird LLP, on Wednesday revealed plans to go private after being bought by Perkins Coie LLP-led Fair Holdings in a $227 million deal.
-
October 15, 2025
3 Firms Guiding S&P's Planned $1.8B Buy Of With Intelligence
S&P Global Inc. said Wednesday it has agreed to acquire With Intelligence, a private markets data and analytics provider, from a group led by majority investor Motive Partners, for $1.8 billion.
-
October 15, 2025
Novo Nordisk Licenses Omeros' Rare Disease Drug For $2.1B
Denmark's Novo Nordisk SA said Wednesday that it will license an antibody from U.S. biopharma Omeros Corp. for up to $2.1 billion in order to expand its portfolio of therapies for rare diseases.
-
October 15, 2025
BlackRock, Nvidia-Led Group Buying Aligned In $40B Deal
The Artificial Intelligence Infrastructure Partnership, MGX and BlackRock's Global Infrastructure Partners said Wednesday they have agreed to acquire Aligned Data Centers from Macquarie Asset Management and co-investors, in a deal valuing Aligned at about $40 billion.
-
October 15, 2025
Altice Rejects €17B Bid From French Telecoms Operators
Telecoms group Altice France said Wednesday that it has "immediately rejected" a €17 billion ($19.8 billion) joint offer from French telecommunications operators Orange, Iliad and Bouygues Telecom for the majority of its domestic operations.
-
October 15, 2025
Advent's $1.3B Bid For Chipmaker Wins Shareholder Backing
U.S. private equity entity Advent said Wednesday that it has persuaded 67.55% of shareholders in Swiss chipmaker U-blox Holding AG to sell their stakes, signaling the success of its 1.03 billion Swiss franc ($1.3 billion) takeover offer.
-
October 14, 2025
NC Court Denies Early Ruling In Hospital Antitrust Case
Owners of a healthcare system in western North Carolina couldn't prevail in an early summary judgment attempt to avoid antitrust claims, after a North Carolina Business Court judge said the complexity of the request at hand precludes a "piecemeal" ruling.
-
October 14, 2025
Freshfields Guides J&J's Planned Orthopedics Unit Spinoff
Johnson & Johnson said Tuesday it intends to separate its orthopedics business into a stand-alone company within the next 18 to 24 months, with Freshfields LLP advising on the planned spinoff of the unit.
-
October 14, 2025
House of Doge To Go Public In Reverse Merger With Brag House
House of Doge, led by Seward & Kissel LLP, will merge with esports platform Brag House Holdings Inc., which is being steered by Lucosky Brookman LLP, in a reverse merger backed by $50 million in capital investments that will see the cryptocurrency company go public.
-
October 14, 2025
Catching Up With Delaware's Chancery Court
Last week at the Delaware Chancery Court, Vice Chancellor Lori W. Will ruled that Carlos Vasallo remains the CEO of Caribevision TV Network LLC, finding that majority investors' attempt to remove him under a defective 2019 agreement was invalid for lack of proper notice.
-
October 14, 2025
Covington, Sidley Guide $700M BioCryst Allergic Disease Deal
BioCryst Pharmaceuticals Inc. will purchase Astria Therapeutics Inc., a biopharmaceutical company focused on therapies for allergic and immunologic diseases, in a cash and stock deal worth about $700 million, the companies announced Tuesday.
-
October 14, 2025
Wachtell, Latham Steer $8.2B Timber Merger Of Equals
Rayonier Inc. and PotlatchDeltic Corp. said Tuesday they have agreed to merge in an all-stock deal that will create an $8.2 billion entity and one of North America's largest publicly traded timber and wood products companies.
-
October 14, 2025
Petershill To Sell Stake In VC Firm To Goldman Sachs
Petershill Partners PLC said Tuesday that it has agreed to sell a majority of its stake in Industry Ventures to Goldman Sachs as a part of the global investment heavyweight's $965 million takeover of the venture capital investor.
-
October 14, 2025
Malibu Life To Buy Texan Life Insurer TruSpire For $45M
Malibu Life Holdings Ltd. said Tuesday that it will buy life and retirement insurance business TruSpire from Mutual of America Life Insurance Co. for $45 million to enter the U.S. direct annuity issuance business.
-
October 13, 2025
Kirkland-Led Warburg Pincus To Buy Software Co. For €700M
Private equity group Warburg Pincus LLC said Monday it has agreed to buy PSI, a German software company, for approximately €702 million ($812 million), to increase its presence in the growing global energy and industrial technology sector.
-
October 13, 2025
7 Firms Guide €16B Merger Of UK, Greek Lottery Operators
Allwyn International AG, the Swiss operator of the U.K. National Lottery and a Greek betting business said Monday that they would merge to form a multinational gambling group valued at €16 billion ($18.5 billion).
-
October 10, 2025
Delta, Aeromexico Say USDOT Erred In Blocking Partnership
Delta Air Lines and Aeromexico have asked the Eleventh Circuit to vacate the U.S. Department of Transportation's order terminating approval of their joint venture and ordering them to dismantle it by January, according to a petition for review posted to the case docket Friday.
-
October 10, 2025
DOJ Can't Pause Review Of UnitedHealth Deal Amid Shutdown
A Maryland federal judge rejected the U.S. Department of Justice's bid to stay its recently settled case with UnitedHealth over the company's merger with Amedisys because of the government shutdown and lapse in appropriations, ruling that a stay would impede the DOJ's ability to evaluate the public interest in the settlement.
-
October 10, 2025
Seyfarth Eyes Middle-Market Bounce As Megadeals Dominate
While multibillion-dollar mergers look good in headlines and have fueled some broader market optimism, Seyfarth attorneys told Law360 on Friday that the middle-market door has yet to fully swing open for a true mergers and acquisitions revival.
-
October 10, 2025
4 Firms Build $972.6M Concrete Biz SPAC Merger
Concrete Partners Holding LLC has unveiled plans to go public through a merger with special purpose acquisition company Haymaker Acquisition Corp. 4 in a deal that was built by four law firms and values the combined company at $972.6 million.
-
October 10, 2025
Covington, Goodwin Guide Bristol Myers' $1.5B Orbital Buy
Bristol Myers Squibb plans to acquire privately held Orbital Therapeutics for $1.5 billion in cash, aiming to expand its pipeline in cell- and RNA-based therapies for autoimmune diseases, the companies announced Friday.
-
October 10, 2025
DOJ Scrutiny Sparks Change To $500M Material Analysis Deal
Onto Innovation Inc. removed a product line from its planned deal to purchase a materials analysis business from Semilab International after the U.S. Department of Justice requested additional information to review the merger, reducing the purchase price to $495 million.
Expert Analysis
-
Del. Dispatch: A Look At Indemnification Notice Provisions
The Delaware Supreme Court's recent decision in Thompson Street Capital Partners v. Sonova U.S. Hearing Instruments serves as a reminder that noncompliance with contractual requirements for an indemnification claim notice may result in forfeiture of the indemnification right, depending on both the agreement language and the circumstances, say attorneys at Fried Frank.
-
Buyer Beware Of Restrictive Covenants In Delaware
Based on recent Delaware Chancery Court opinions rejecting restricted covenants contained in agreements in the sale-of-business context, businesses need to craft narrowly tailored restrictions that have legitimate interests, say attorneys at Saul Ewing.
-
ESOP Ruling Clarifies Trustees' Role In 3rd-Party Sales
An Illinois federal court's dismissal of a class action related to an employee stock ownership plan in Rush v. GreatBanc demystifies the trustee's role in a sale transaction to a third party by providing commentary on the prudent process and considerations for trustees to weigh before approving a sale, says Katelyn Harrell at BCLP.
-
Google Ad Tech Ruling Creates Antitrust Uncertainty
A Virginia federal court’s recent decision in the Justice Department’s ad tech antitrust case against Google includes two unusual aspects in that it narrowly construed U.S. Supreme Court precedent when rejecting Google's two-sided market argument, and it found the company liable for unlawful tying, say attorneys at Ballard Spahr.
-
Series
Brazilian Jiujitsu Makes Me A Better Lawyer
Competing in Brazilian jiujitsu – often against opponents who are much larger and younger than me – has allowed me to develop a handful of useful skills that foster the resilience and adaptability necessary for a successful legal career, says Tina Dorr of Barnes & Thornburg.
-
Opportunities And Challenges For The Texas Stock Exchange
While the new Texas Stock Exchange could be an interesting alternative to the NYSE and the Nasdaq due to the state’s robust economy and the TXSE’s high-profile leadership and publicity opportunities for listings, its success as a national securities exchange may hinge on resolving questions about its regulatory and cost advantages, say attorneys at Norton Rose.
-
Pace Of Early Terminations Suggests Greater M&A Scrutiny
The nascent return of early termination under the Hart-Scott-Rodino Act shows a more limited use than before its 2021 suspension under the Biden administration's Federal Trade Commission, suggesting deeper scrutiny of mergers and acquisitions across the board, says Michael Wise at Squire Patton.
-
Review Risk Is Increasing For Foreign Real Estate Developers
Federal and state government efforts have been expanding oversight of foreign investment in U.S. real estate, necessitating careful assessment of risk and of the benefits of notifying the Committee on Foreign Investment in the United States, say attorneys at Troutman.
-
Series
Power To The Paralegals: An Untapped Source For Biz Roles
Law firms looking to recruit legal business talent should consider turning to paralegals, who practice several key skills every day that prepare them to thrive in marketing and client development roles, says Vanessa Torres at Lowenstein Sandler.
-
The Legal Risks Of US Restrictions On Investments In China
The second Trump administration has continued to embrace a more restrictive economic policy toward China, including an ongoing review of further restrictions on the flow of U.S. capital to China, so early planning and enhanced diligence can reduce exposure to the challenges resulting from further restrictions, say attorneys at Cleary.
-
Series
Playing Poker Makes Me A Better Lawyer
Poker is a master class in psychology, risk management and strategic thinking, and I’m a better attorney because it has taught me to read my opponents, adapt when I’m dealt the unexpected and stay patient until I'm ready to reveal my hand, says Casey Kingsley at McCreadyLaw.
-
Does R-Squared Have A Role In Event Study Analysis?
With 2024 marking the second consecutive year to experience an increase in securities class action filings, determining the reliability of event study models is of utmost importance, but it's time to reconsider the traditional method of doing so, say analysts at StoneTurn Group.
-
4 Ways Slater Is Priming DOJ For Continued Antitrust Success
Just as Jonathan Kanter did during his recent tenure leading the U.S. Department of Justice's Antitrust Division, Assistant Attorney General Gail Slater is following the effective blueprint set by Thurman Arnold when he modernized the division more than 80 years ago, says Perry Apelbaum at Kressin Powers.
-
What EU 'Killer Acquisition' Study Means For Pharma Deals
The European Commission’s recent study of pharmaceutical companies' acquisitions of emerging competitive threats, the first of its kind globally, has important implications for the industry, and may lead to increased awareness of merger control risks in collaborative agreements, say lawyers at Paul Weiss.
-
Key Aspects Of FDIC's Resolution Planning FAQ
The Federal Deposit Insurance Corp.'s recent FAQ on changes to its resolution plan rule ease burdensome requirements for some large institutions and exempt others from discussion of franchise components, making it easier for banks to finalize submissions before the July 1 deadline, say attorneys at Moore & Van Allen.